SEC Charges Zymergen Inc. With Misleading IPO Investors About Company’s Market Potential and Sales Prospects

Sep 13, 2024

The Securities and Exchange Commission today announced settled charges against Zymergen Inc., an Emeryville, California-based biotechnology company, for misleading IPO investors about its overall market potential, revenue prospects, and customer pipeline…

Full report at: Read More

More News

Self-Described Racist Skinhead Sentenced for Race-Based Threats via Social Media Against Black Neighbors in Maine

SEC Charges Kraken for Operating as an Unregistered Securities Exchange, Broker, Dealer, and Clearing Agency

Sommers Schwartz, P.C. Unmasks Sexual Abuse Allegations Against Father Richard T. Craig

Federal Court Permanently Shuts Down Texas Tax Return Preparer

SEC Charges Former Chairman and CEO of Tech Co. Kubient With Fraud and Lying to Auditors

Richard Wirtz Receives Martindale-Hubbell Silver Client Champion Award

SEC Charges Cassava Sciences, Two Former Executives for Misleading Claims About Alzheimer’s Clinical Trial

FROM:

Brill & Rinaldi, The Law Firm, Reaches Settlement in Traumatic Brain Injury Case Following Construction Site Accident

FROM:

Former Methode Electronics Executive Files Lawsuit Alleging Defamation, Wrongful Interference, and Emotional Distress

FROM:

Brill & Rinaldi, The Law Firm, Reaches Settlement in Traumatic Brain Injury Case Following Construction Site Accident

FROM: